AAAAAA

   
Results: 1-21 |
Results: 21
ASSESSMENT OF PLATELET-FUNCTION ASSAYS
Authors: NICHOLSON NS PANZERKNODLE SG HAAS NF TAITE BB SZALONY JA PAGE JD FEIGEN LP LANSKY DM SALYERS AK
Citation: Ns. Nicholson et al., ASSESSMENT OF PLATELET-FUNCTION ASSAYS, The American heart journal, 135(5), 1998, pp. 170-178
ORBOFIBAN IS A NEW ORALLY-ACTIVE ANTIPLATELET AGENT ACTING BY ANTAGONISM OF FIBRINOGEN BINDING
Authors: NICHOLSON NS TAITE BB SZALONY JA SALVERS AK HAAS NF PANZERKNODLE SK ENGLEMAN VW FEIGEN LP PAGE JD SEARLE GD
Citation: Ns. Nicholson et al., ORBOFIBAN IS A NEW ORALLY-ACTIVE ANTIPLATELET AGENT ACTING BY ANTAGONISM OF FIBRINOGEN BINDING, The FASEB journal, 12(5), 1998, pp. 4174-4174
PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN
Authors: SZALONY JA TAITE BB FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS
Citation: Ja. Szalony et al., PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN, The FASEB journal, 12(5), 1998, pp. 4175-4175
PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN
Authors: FREDERICK LG SULEYMANOV OD SZALONY JA TAITE BB SALYERS AK KING LW FEIGEN LP NICHOLSON NS
Citation: Lg. Frederick et al., PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN, Circulation, 98(8), 1998, pp. 813-820
THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/, Circulation, 93(1), 1996, pp. 129-134
CHARACTERIZATION OF BINDING OF AN RGD MIMETIC, [H-3] SC-52012, TO PLATELET GPIIB IIIA/
Authors: PANZERKNODLE SG JACQMIN P PAGE JD NICHOLSON NS ZABLOCKI JA ENGLEMAN VW FEIGEN LP
Citation: Sg. Panzerknodle et al., CHARACTERIZATION OF BINDING OF AN RGD MIMETIC, [H-3] SC-52012, TO PLATELET GPIIB IIIA/, Platelets, 6(5), 1995, pp. 288-295
ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, The FASEB journal, 9(3), 1995, pp. 55-55
EFFECTS OF THE GP IIB IIIA ANTAGONIST SC-54701 ON FIBRIN GENERATION AND PLATELET-FIBRIN INTERACTIONS IN THROMBIN-INDUCED CLOT FORMATION ANDRETRACTION/
Authors: PAGE JD BARON DA HAAS NF NICHOLSON NS FEIGEN LP
Citation: Jd. Page et al., EFFECTS OF THE GP IIB IIIA ANTAGONIST SC-54701 ON FIBRIN GENERATION AND PLATELET-FIBRIN INTERACTIONS IN THROMBIN-INDUCED CLOT FORMATION ANDRETRACTION/, Thrombosis and haemostasis, 73(6), 1995, pp. 1315-1315
ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/
Authors: FEIGEN LP FREDERICK LG KING LW SULEYMANOV OD NICHOLSON NS
Citation: Lp. Feigen et al., ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1333-1333
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: ZABLOCKI JA RICO JG GARLAND RB ROGERS TE WILLIAMS K SCHRETZMAN LA RAO SA BOVY PR TJOENG FS LINDMARK RJ TOTH MV ZUPEC ME MCMACKINS DE ADAMS SP MIYANO M MARKOS CS MILTON MN PAULSON S HERIN M JACQMIN P NICHOLSON NS PANZERKNODLE SG HAAS NF PAGE JD SZALONY JA TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(13), 1995, pp. 2378-2394
SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG SALYERS AK TAITE BB SZALONY JA HAAS NF KING LW ZABLOCKI JA KELLER BT BROSCHAT K ENGLEMAN VW HERIN M JACQMIN P FEIGEN LP
Citation: Ns. Nicholson et al., SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION, Circulation, 91(2), 1995, pp. 403-410
EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A
Authors: SZALONY JA HAAS NF SALYERS AK TAITE BB NICHOLSON NS MEHROTRA DV FEIGEN LP
Citation: Ja. Szalony et al., EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A, Circulation, 91(2), 1995, pp. 411-416
A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/
Authors: SALYERS AK SZALONY JA TAITE BB HAAS NF MEHROTRA DV FEIGEN LP NICHOLSON NS
Citation: Ak. Salyers et al., A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/, Thrombosis research, 75(4), 1994, pp. 409-417
SC-49992 - A POTENT AND SPECIFIC INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG KING LW TAITE BB KELLER BT TJOENG FS ENGLEMAN VW GIORGIO TD FEIGEN LP
Citation: Ns. Nicholson et al., SC-49992 - A POTENT AND SPECIFIC INHIBITOR OF PLATELET-AGGREGATION, Thrombosis research, 74(5), 1994, pp. 523-535
BIOTINIDASE DEFICIENCY - EARLY NEUROLOGICAL PRESENTATION
Authors: COLLINS JE NICHOLSON NS DALTON N LEONARD JV
Citation: Je. Collins et al., BIOTINIDASE DEFICIENCY - EARLY NEUROLOGICAL PRESENTATION, Developmental Medicine and Child Neurology, 36(3), 1994, pp. 268-270
DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE
Authors: NICHOLSON NS HAAS NF TAITE BB PANZERKNODLE SG KING LW ABOOD NA ZABLOCKI JA RICO JG SMITH JW FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181
DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE
Authors: NICHOLSON NS HAAS NF TAITE BB PANZERKNODLE SG KING LW ABOOD NA ZABLOCKI JA RICO JG SMITH JW FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181
CHARACTERIZATION OF A PEPTIDE MIMETIC LIGAND ([3H]SC-52012) BINDING TO PLATELET GP IIB IIIA RECEPTOR/
Authors: PAGE JD PANZERKNODLE SG JACQMIN P NICHOLSON NS ZABLOCKI JA ENGLEMAN VW FEIGEN LP
Citation: Jd. Page et al., CHARACTERIZATION OF A PEPTIDE MIMETIC LIGAND ([3H]SC-52012) BINDING TO PLATELET GP IIB IIIA RECEPTOR/, Blood, 84(10), 1994, pp. 10000689-10000689
SPECIES VARIATION IN THE EFFECT OF GLYCOPROTEIN-IIB IIIA ANTAGONISTS ON INHIBITION OF PLATELET-AGGREGATION/
Authors: PANZERKNODLE S TAITE BB MEHROTRA DV NICHOLSON NS FEIGEN LP
Citation: S. Panzerknodle et al., SPECIES VARIATION IN THE EFFECT OF GLYCOPROTEIN-IIB IIIA ANTAGONISTS ON INHIBITION OF PLATELET-AGGREGATION/, Journal of pharmacological and toxicological methods, 30(1), 1993, pp. 47-53
SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: FEIGEN LP NICHOLSON NS KING LW CAMPION JG TJOENG FS PANZERKNODLE SG
Citation: Lp. Feigen et al., SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1191-1197
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP-PHE SEQUENCE OF FIBRINOGEN - A PROPOSAL ON THE NATURE OF THE BINDING INTERACTION BETWEEN THE ARG-GUANIDINE OF RGDX MIMETICS AND THE PLATELET GP IIB-IIIA RECEPTOR
Authors: ZABLOCKI JA MIYANO M GARLAND RB PIREH D SCHRETZMAN L RAO SN LINDMARK RJ PANZERKNODLE SG NICHOLSON NS TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP-PHE SEQUENCE OF FIBRINOGEN - A PROPOSAL ON THE NATURE OF THE BINDING INTERACTION BETWEEN THE ARG-GUANIDINE OF RGDX MIMETICS AND THE PLATELET GP IIB-IIIA RECEPTOR, Journal of medicinal chemistry, 36(13), 1993, pp. 1811-1819
Risultati: 1-21 |